PDB31 COST-EFFECTIVENESS OF DETEMIRVERSUS NPH FORTYPE I DIABETES PATIENTS TREATED WITH BASAL-BOLUS THERAPY IN PORTUGAL
May 1, 2008, 00:00 AM
10.1016/S1098-3015(10)70719-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)70719-1/fulltext
Section Title :
Section Order :
462
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70719-1&doi=10.1016/S1098-3015(10)70719-1